The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Advances in tuberculosis vaccine strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Centers for Disease Control and Prevention
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n74 · Cited by 6,444
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,349
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997) · Science · doi:10.1126/science.277.5327.818 · Cited by 1,664
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,542
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461
Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Tuberculosis: Pathogenesis, Protection and Control
(1996) · Nature Medicine · doi:10.1038/nm0296-244b · Cited by 977
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi, S., Revy, P., Emile, J.-F., Newport, M., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 895
Similarities and differences in CD4+ and CD8+ effector and memory T cell generation
Seder, R. A., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni969 · Cited by 892
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B., & Bloom, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12013 · Cited by 792
Global tuberculosis incidence and mortality during 1990-2000.
Pj, D., Raviglione, M. C., & Kochi, A. (1994) · PubMed · Cited by 768
Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E., & Fineberg, H. V. (1995) · Pediatrics · doi:10.1542/peds.96.1.29 · Cited by 763
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Cole, S. T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03237.x · Cited by 729
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., & Cole, S. T. (2003) · Nature Medicine · doi:10.1038/nm859 · Cited by 644
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 629
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Grode, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24617 · Cited by 557
Tuberculosis: a global overview of the situation today.
Sudre, P., ten Dam, G., & Kochi, A. (1992) · Europe PMC (PubMed Central) · Cited by 539
Gordon, S. V., Brosch, R., Billault, A., Garnier, T., Eiglmeier, K., & Cole, S. T. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01383.x · Cited by 537
Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S. E., Fondanèche, M.-C., Dupuis, S., Döffinger, R., Altare, F., Girdlestone, J., Emile, J.-F., et al. (1999) · Nature Genetics · doi:10.1038/7701 · Cited by 492
Capuano, S. V., Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., Bissel, S., Fuhrman, C., Klein, E., & Flynn, J. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5831-5844.2003 · Cited by 479
Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Béthune, M.-P., Kostense, S., Penders, G., Helmus, N., Koudstaal, W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8263-8271.2003 · Cited by 467
Horwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Tuberculosis: Pathogenesis, protection, and control
De Cock, K. M. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90122-1 · Cited by 417
An essential role for phoP in Mycobacterium tuberculosis virulence
Pérez, E., Samper, S., Bordas, Y., Guilhot, C., Gicquel, B., & Martín, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02500.x · Cited by 379
Control of latentMycobacterium tuberculosis infection is dependent on CD8 T cells
van Pinxteren, L. A. H., Cassidy, J. P., Smedegaard, B. H. C., Agger, E. M., & Andersen, P. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12<3689::aid-immu3689>3.0.co;2-4 · Cited by 366
Goonetilleke, N. P., McShane, H., Hannan, C. M., Anderson, R. J., Brookes, R. H., & Hill, A. V. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1602 · Cited by 360
Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M., & Xing, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6357 · Cited by 359
Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.
Andersen, P., Andersen, A. B., Sørensen, A. L., & Nagai, S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.7.3359 · Cited by 351
Olsen, A. W., van Pinxteren, L. A. H., Okkels, L. M., Rasmussen, P. B., & Andersen, P. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2773-2778.2001 · Cited by 344
Long-term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60-Year Follow-up Study
Aronson, N. E., Santosham, M., Comstock, G. W., Howard, R. S., Moulton, L. H., Rhoades, E. R., & Harrison, L. H. (2004) · JAMA · doi:10.1001/jama.291.17.2086 · Cited by 338
Sambandamurthy, V. K., Wang, X., Chen, B., Russell, R. G., Derrick, S., Collins, F. M., Morris, S. L., & Jacobs, W. R. (2002) · Nature Medicine · doi:10.1038/nm765 · Cited by 336
Ulrichs, T., Kosmiadi, G. A., Trusov, V., Jörg, S., Pradl, L., Titukhina, M., Mishenko, V., Gushina, N., & Kaufmann, S. H. (2004) · The Journal of Pathology · doi:10.1002/path.1628 · Cited by 331
Nagai, S., Wiker, H. G., Harboe, M., & Kinomoto, M. (1991) · Infection and Immunity · doi:10.1128/iai.59.1.372-382.1991 · Cited by 319
Skeiky, Y. A. W., Alderson, M. R., Ovendale, P. J., Guderian, J. A., Brandt, L., Dillon, D. C., Campos-Neto, A., Lobet, Y., Dalemans, W., Orme, I. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7618 · Cited by 313
Self-citationDoes the efficacy of BCG decline with time since vaccination?
Sterne, J. A. C., Rodrigues, L. C., & Guedes, I. N. (1998) · PubMed · Cited by 310
The BCG Story: Lessons from the Past and Implications for the Future
Fine, P. E. M. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_2.s353 · Cited by 295
Skjøt, R. L. V., Oettinger, T., Rosenkrands, I., Ravn, P., Brock, I., Jacobsen, S., & Andersen, P. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.214-220.2000 · Cited by 294
Soysal, A., Millington, K. A., Bakir, M., Dosanjh, D., Aslan, Y., Deeks, J. J., Efe, S., Staveley, I., Ewer, K., & Lalvani, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67534-4 · Cited by 291
A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15688 · Cited by 275
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
Kaufmann, S. H. E., & McMichael, A. J. (2005) · Nature Medicine · doi:10.1038/nm1221 · Cited by 273
Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis
Baldwin, S. L., D’Souza, C., Roberts, A. D., Kelly, B. P., Frank, A. A., Lui, M. A., Ulmer, J. B., Huygen, K., McMurray, D. M., & Orme, I. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2951-2959.1998 · Cited by 272
Tuberculosis and the Tubercle Bacillus
(2004) · Wiley eBooks · doi:10.1128/9781555817657 · Cited by 270
Dietrich, J., Aagaard, C., Leah, R., Olsen, A. W., Stryhn, A., Doherty, T. M., & Andersen, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6332 · Cited by 252
Smith, D. A., Parish, T., Stoker, N. G., & Bancroft, G. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1442-1150.2001 · Cited by 243
Gonzalez-Juarrero, M., Turner, O. C., Turner, J., Marietta, P., Brooks, J. V., & Orme, I. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1722-1728.2001 · Cited by 221
The BCG Experience: Implications for Future Vaccines against Tuberculosis
Bloom, B. R., & Fine, P. E. M. (2014) · Tuberculosis · doi:10.1128/9781555818357.ch31 · Cited by 220
Horwitz, M. A., & Harth, G. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1672-1679.2003 · Cited by 201
Hess, J., Miko, D., Catic, A., Lehmensiek, V., Russell, D. G., & Kaufmann, S. H. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5299 · Cited by 197
Hopewell, P. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.540 · Cited by 196
Iron-cofactored Superoxide Dismutase Inhibits Host Responses to Mycobacterium tuberculosis
EDWARDS, K. M., CYNAMON, M. H., VOLADRI, R. K. R., HAGER, C. C., DeSTEFANO, M. S., THAM, K. T., LAKEY, D. L., BOCHAN, M. R., & KERNODLE, D. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.12.2106093 · Cited by 196
Andersen, A. B., & Hansen, E. B. (1989) · Infection and Immunity · doi:10.1128/iai.57.8.2481-2488.1989 · Cited by 183
Brandt, L., Skeiky, Y. A. W., Alderson, M. R., Lobet, Y., Dalemans, W., Turner, O. C., Basaraba, R. J., Izzo, A. A., Lasco, T. M., Chapman, P. L., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6622-6632.2004 · Cited by 174
Self-citationLipoprotein antigens ofMycobacterium tuberculosis
Young, D. B., & Garbe, T. R. (1991) · Research in Microbiology · doi:10.1016/0923-2508(91)90097-t · Cited by 172
Skjøt, R. L. V., Brock, I., Arend, S. M., Munk, M. E., Theisen, M., Ottenhoff, T. H. M., & Andersen, P. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5446-5453.2002 · Cited by 169
Auxotrophic vaccines for tuberculosis
Guleria, I., Teitelbaum, R., McAdam, R. A., Kalpana, G., Jacobs, W. R., & Bloom, B. R. (1996) · Nature Medicine · doi:10.1038/nm0396-334 · Cited by 166
Mazurek, G. H., & Villarino, M. E. (2003) · PubMed · Cited by 166
Persistence and Protective Efficacy of a Mycobacterium tuberculosis Auxotroph Vaccine
Jackson, M., Phalen, S. W., Lagranderie, M., Ensergueix, D., Chavarot, P., Marchal, G., McMurray, D. N., Gicquel, B., & Guilhot, C. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2867-2873.1999 · Cited by 164
Mattow, J., Schaible, U. E., Schmidt, F., Hagens, K., Siejak, F., Brestrich, G., Haeselbarth, G., Müller, E., Jungblut, P. R., & Kaufmann, S. H. E. (2003) · ELECTROPHORESIS · doi:10.1002/elps.200305601 · Cited by 163
Dillon, D. C., Alderson, M. R., Day, C. H., Lewinsohn, D. M., Coler, R. N., Bement, T., Campos‐Neto, A., Skeiky, Y. A. W., Orme, I. M., Roberts, A. D., et al. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2941-2950.1999 · Cited by 159
Self-citationThe use of TNF-? blocking agents in rheumatoid arthritis: an overview
Toussirot, É., & Wendling, D. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.3.581 · Cited by 145
Bouneaud, C., Garcia, Z., Kourilsky, P., & Pannetier, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040876 · Cited by 144
Tuberculosis and the Tubercle Bacillus
Liu, J. (2005) · Emerging infectious diseases · doi:10.3201/eid1108.050611 · Cited by 141
Sambandamurthy, V. K., Derrick, S. C., Jalapathy, K. V., Chen, B., Russell, R. G., Morris, S. L., & Jacobs, W. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.1196-1203.2005 · Cited by 138
(1994) · ASM Press eBooks · doi:10.1128/9781555818357 · Cited by 138
Portnoy, D. A., Tweten, R. K., Kehoe, M., & Bielecki, J. (1992) · Infection and Immunity · doi:10.1128/iai.60.7.2710-2717.1992 · Cited by 130
Kochi, A. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001000100014 · Cited by 128
Chattergoon, M. A., Kim, J. J., Yang, J.-S., Robinson, T. M., Lee, D. J., Dentchev, T., Wilson, D. M., Ayyavoo, V., & Weiner, D. B. (2000) · Nature Biotechnology · doi:10.1038/79470 · Cited by 125
Comparative genomics of the mycobacteria
Brosch, R., Gordon, S. V., Pym, A. S., Eiglmeier, K., Garnier, T., & Cole, S. T. (2000) · International Journal of Medical Microbiology · doi:10.1016/s1438-4221(00)80083-1 · Cited by 125
Dillon, D. C., Alderson, M. R., Day, C. H., Bement, T., Campos‐Neto, A., Skeiky, Y. A. W., Vedvick, T., Badaró, R. J. D. S., Reed, S. G., & Houghton, R. L. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3285-3290.2000 · Cited by 124
Self-citationKamath, A. T., Fruth, U., Brennan, M. J., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.001 · Cited by 120
Alderson, M. R., Bement, T., Day, C. H., Zhu, L., Molesh, D. A., Skeiky, Y. A. W., Coler, R. N., Lewinsohn, D. M., Reed, S. G., & Dillon, D. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.551 · Cited by 119
Self-citationSoto, C. Y., Menendez, M. C., Pérez‐Herrán, E., Samper, S., Gómez, A. B., García, M. J., & Martı́n, C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.212-219.2004 · Cited by 119
Skeiky, Y. A. W., Lodes, M. J., Guderian, J. A., Mohamath, R., Bement, T., Alderson, M. R., & Reed, S. G. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3998-4007.1999 · Cited by 118
Self-citationBrewer, T. F., & Colditz, G. A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.126 · Cited by 112
Field trials of tuberculosis vaccines: How could we have done them better?
Comstock, G. W. (1994) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)90042-6 · Cited by 100
Detection of Deleted Genomic DNA Using a Semiautomated Computational Analysis of GeneChip DataPreprint
Salamon, H., Kato‐Maeda, M., Small, P. M., Drenkow, J., & Gingeras, T. (2000) · Genome Research · doi:10.1101/gr.gr-1529r · Cited by 72
Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis
Sambandamurthy, V. K., & Jacobs, W. R. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.04.001 · Cited by 65
Derrick, S. C., Repique, C. J., Snoy, P. J., Yang, A. L., & Morris, S. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1685-1692.2004 · Cited by 63
Fifteen year follow up of trial of BCG vaccines in south India for tuberculosis prevention. 1999.
(2013) · PubMed Central · Cited by 40
Improved protection by recombinant BCG
Eddine, A. N., & Kaufmann, S. H. E. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.012 · Cited by 39
Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.
Lp, O., Horsfield, N., & Rm, G. (2002) · PubMed · Cited by 31
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
Jagannath, C., Lindsey, D. R., Dhandayuthapani, S., Xu, Y., Hunter, R. L., & Eissa, N. T. (2009) · Nature Medicine · doi:10.1038/nm.1928 · Cited by 494
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
Abu-Raddad, L. J., Sabatelli, L., Achterberg, J. T., Sugimoto, J. D., Longini, I. M., Dye, C., & Halloran, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901720106 · Cited by 348
Confronting the scientific obstacles to global control of tuberculosis
Young, D. B., Perkins, M. D., Duncan, K., & Barry, C. E. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34614 · Cited by 324
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rappuoli, R., & Aderem, A. (2011) · Nature · doi:10.1038/nature10124 · Cited by 273
Metadata
- Authors
- Skeiky, Y. A. W., & Sadoff, J. C.
- Venue
- Nature Reviews Microbiology
- Published
- 2006-06-01
- Volume
- 4
- Issue
- 6
- Pages
- 469-476
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2093423705
- Cited by
- 299
- References
- 90
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.